Low prevalence of hepatitis C virus infection among HIV-Positive patients: Data from a large-scale cohort study in Istanbul, Turkey

Hepatitis Monthly

Volumn 14, Issue 8, 2014, Pages

  Altuntas Aydin, Ozlem ^a   Yemisen, Mucahit ^b   Kumbasar Karaosmanoglu, Hayat ^a   Sargin, Fatma ^c   Gunduz, Alper ^d   Ceylan, Bahadir ^e   Mete, Bilgul ^b   Ozgunes, Nail ^c   Yildiz Sevgi, Dilek ^d   Ozaras, Resat ^b   Tabak, Fehmi ^b  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c ISTANBUL MEDENIYET UNIVERSITY   (Turkey)

^d SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e BEZMIALEM VAKIF UNIVERSITY   (Turkey)

Author keywords

Hepatitis C virus; Human immunodeficiency virus; Prevalence; Turkey

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; DEMOGRAPHY; DISEASE TRANSMISSION; DRUG USE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GENOTYPE; HEPATITIS C; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEN WHO HAVE SEX WITH MEN; MIXED INFECTION; POLYMERASE CHAIN REACTION; PREVALENCE; PRISON; RISK FACTOR; SEXUAL BEHAVIOR; TURKEY (REPUBLIC);

EID: 84921987661     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.18128     Document Type: Article

References (32)

1. Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res. 2010;85(1):303-15.
2. Naggie S, Sulkowski MS. Management of patients coinfected with HCV and HIV: a close look at the role for direct-acting antivirals. Gastroenterology. 2012;142(6):1324-1334+e3.
3. Andreoni M, Giacometti A, Maida I, Meraviglia P, Ripamonti D, Sarmati L. HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. Eur Rev Med Pharmacol Sci. 2012;16(11):1473-83.
4. Guidelines.: EACS European ADS Clinical Society; 2012.
5. Wilkins E, Nelson M, Agarwal K, Awoyemi D, Barnes E, Bhagani S, et al. British HIV Association guidelines for the management of hepatitis viruses in adults infected with HIV 2013. HIV Med. 2013;14(S4):1-71.
6. Aberg JA, Gallant JE, Ghanem KG, Emmanuel P, Zingman BS, Horberg MA. Primary care guidelines for the management of persons infected with HIV: 2013 update by the HIV medicine association of the infectious diseases society of America. Clinical Infect Dis. 2013:cit665.
7. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5(9):558-67.
8. Kilmarx PH. Global epidemiology of HIV. Curr Opin HIV AIDS. 2009;4(4):240-6.
9. Keramat F, Eini P, Majzoobi MM. Seroprevalence of HIV, HBV and HCV in Persons Referred to Hamadan Behavioral Counseling Center, West of Iran. Iran Red Crescent Med J. 2011;13(1):42-6.
10. Larsen C, Pialoux G, Salmon D, Antona D, Le Strat Y, Piroth L, et al. Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004. Euro Surveill. 2008;13(22):717-27.
11. Browne R, Asboe D, Gilleece Y, Atkins M, Mandalia S, Gazzard B, et al. Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase? Sex Transm Infect. 2004;80(4):326-7.
12. van de Laar TJ, van der Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, et al. Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis. 2007;196(2):230-8.
13. Matthews GV, Dore GJ. HIV and hepatitis C coinfection. J Gastroenterol Hepatol. 2008;23(7 PART 1):1000-8.
14. Taylor LE, Swan T, Mayer KH. HIV coinfection with hepatitis C virus: evolving epidemiology and treatment paradigms. Clin Infect Dis. 2012;55 Suppl 1:S33-42.
15. Ataei B, Tayeri K, Kassaian N, Farajzadegan Z, Babak A. Hepatitis B and C among patients infected with human immunodeficiency virus in Isfahan, Iran: seroprevalence and associated factors. Hepat Mon. 2010;10(3):188-92.
16. SeyedAlinaghi S, Jam S, Mehrkhani F, Fattahi F, Sabzvari D, Kourorian Z, et al. Hepatitis-C and hepatitis-B co-infections in patients with human immunodeficiency virus in Tehran, Iran. Acta Med Iran. 2011;49(4):252-7.
17. Olinger CM, Lazouskaya NV, Eremin VF, Muller CP. Multiple genotypes and subtypes of hepatitis B and C viruses in Belarus: similarities with Russia and western European influences. Clin Microbiol Infect. 2008;14(6):575-81.
18. Trevino A, Rivas P, Herrero-Mendoza M, Toro C, Soriano V, de Mendoza C, editors. Newly Diagnosed HIV-1 Individuals in Spain since Year 2000. Non-B Subtypes, and Hepatitis C and B Virus Coinfections.; 16th Conference on Retroviruses and Opportunistic Infections.; 2009; Montreal, Canada. Montreal, Canada: 2009. p. p. 300.
19. Oliveira-Filho AB, Oliveira EH, Castro JA, Silva LV, Vallinoto AC, Lemos JA. Epidemiological aspects of HCV infection in HIVinfected individuals in Piaui State, Northeast Brazil. Arch Virol. 2012;157(12):2411-6.
20. HATAM. HIV/AIDS cases according to the year of Distribution. Ankara: T. C. Ministry of Health; 2013. Available from: http://www.hatam.hacettepe.edu.tr/verilerAralik2012.pdf.
21. Karaosmanoglu HK, Aydin OA, Nazlican O. Profile of HIV/AIDS patients in a tertiary hospital in Istanbul, Turkey. HIV Clin Trials. 2011;12(2):104-8.
22. Tozun N, Ozdogan OC, Cakaloglu Y, Idilman R, Karasu Z, Aakarca US, et al. Nationwide prevalence study and risk factors for hepatitis A, B, C and D infections in Turkey. Hepatology. 2010;52(SUPPL 1):697A.
23. Mistik, R. Hepatit C virus infection epidemiology. In: Tabak, F., Tosun, S. editors. Viral Hepatit 2013. Istanbul: Istanbul Ti{dotless}p Kitabevi; 2013. pp. 83-113.
24. Karaca C, Cakaloglu Y, Demir K, Ozdil S, Kaymakoglu S, Badur S, et al. Risk factors for the transmission of hepatitis C virus infection in the Turkish population. Dig Dis Sci. 2006;51(2):365-9.
25. Ministry of Interior General Directorate of Security. TC drug report Ministry of Interior General Directorate of Security Department of Anti-Smuggling and Organized Crime. Ankara; 2013.
26. Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS. 2007;21(8):983-91.
27. Fierer DS, Factor SH, Uriel AJ, Carriero DC, Klepper A, Dietrich DT. Sexual transmission of hepatitis C virus among HIV-infected men who have sex with men--New York City, 2005-2010. MMWR. 2011;60(28):945.
28. Gamage DG, Read TR, Bradshaw CS, Hocking JS, Howley K, Chen MY, et al. Incidence of hepatitis-C among HIV infected men who have sex with men (MSM) attending a sexual health service: a cohort study. BMC Infect Dis. 2011;11:39.
29. Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, et al. Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS. 2009;23(12):F1-7.
30. Simmonds P, Bukh J, Combet C, Deleage G, Enomoto N, Feinstone S, et al. Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology. 2005;42(4):962-73.
31. Sy T, Jamal MM. Epidemiology of hepatitis C virus (HCV) infection. Int J Med Sci. 2006;3(2):41-6.
32. Tahan V, Ozaras R, Karaca C, Uraz S, Eren F, Danalioglu A, et al. Is HCV genotyping cost-effective even when the prevalences of genotypes 2 and 3 are low? Hepatogastroenterology. 2009;56(94/95):1425-8.